Edition:
United States

Sinopharm Group Co Ltd (1099.HK)

1099.HK on Hong Kong Stock

34.75HKD
23 May 2017
Change (% chg)

HK$-0.05 (-0.14%)
Prev Close
HK$34.80
Open
HK$35.00
Day's High
HK$35.00
Day's Low
HK$34.50
Volume
3,716,511
Avg. Vol
4,972,119
52-wk High
HK$42.50
52-wk Low
HK$31.20

Latest Key Developments (Source: Significant Developments)

Sinopharm Group says qtrly total operating revenue RMB 68.42 bln
Tuesday, 25 Apr 2017 08:21pm EDT 

April 26 (Reuters) - Sinopharm Group Co Ltd <1099.HK> ::Qtrly total operating revenue RMB 68.42 billion versus RMB 63.07 billion.Qtrly net profit attributable to equity holders of the company RMB 1.25 billion versus RMB 1.02 billion.  Full Article

Sinopharm Group Co records FY net profit of RMB6.89 billion, an increase of 20.04 pct
Friday, 24 Mar 2017 07:55am EDT 

Sinopharm Group Co Ltd <1099.HK> : Recorded a fy net profit of rmb6,891.60 million, representing an increase of rmb1,150.69 million or 20.04% . Fy group revenue of rmb258,387.69 million, representing an increase of 12.99% .A final dividend for year ended 31 december 2016 of rmb0.50 (tax inclusive) per ordinary share.  Full Article

Sinopharm Group Co says Wei Yulin tendered his resignation as chairman
Friday, 24 Mar 2017 07:44am EDT 

Sinopharm Group Co Ltd <1099.HK> : Wei Yulin , due to fact that he has reached retirement age, has tendered his resignation on 24 march 2017 as chairman .Li Zhiming, executive director and president of company, and a member of investment committee of board, was elected as chairman of board.  Full Article

Sinopharm posts half-year net profit of RMB 2.53 billion<1099.HK>
Sunday, 21 Aug 2016 08:02pm EDT 

Sinopharm Group Co Ltd <1099.HK>: Announcement on 2016 interim results <1099.HK> . Says no interim dividend was proposed for the six-month period ended 30 June 2016 . HY profit attributable to owners of the parent RMB 2.53 billion versus RMB 1.91 billion . Says HY revenue RMB 125.89 billion versus RMB 111.06 billion . The group has sufficient financial resources for ongoing operation in the foreseeable future" .  Full Article

Sinopharm updates on proposed adoption of restricted share incentive scheme<1099.HK>
Friday, 19 Aug 2016 06:16am EDT 

Sinopharm Group Co Ltd <1099.HK>: Announcement proposed adoption of restricted share incentive scheme <1099.HK> . Proposes to adopt the scheme to closely align the interests and benefits of and risks sharing among the shareholders, the company and the employees .  Full Article

Sinopharm updates on participation in pilot works of developing mixed-ownership economy<1099.HK>
Thursday, 18 Aug 2016 04:31am EDT 

Sinopharm Group Co Ltd <1099.HK>: Informed that CNPGC has obtained the "approval on implementation of share incentive scheme of Sinopharm Group Co Ltd" . Approval from the state-owned assets supervision and administration commission of the state council .  Full Article

Sinopharm Group proposes to dispose assets to Sinopharm (CNCM ltd)<1099.HK>
Wednesday, 20 Jul 2016 09:05am EDT 

Sinopharm Group Co Ltd <1099.HK>: Discloseable transactions proposed disposal of equity interests in certain subsidiaries held by the company to Sinopharm (CNCM Ltd) and connected transaction deemed disposal of equity interests in Sinopharm (CNCM Ltd) . Company, Sinopharm (CNCM Ltd), and the other minority shareholders entered into assets transfer agreements . Says aggregate consideration of approximately RMB5.37 billion . Company proposed to dispose the target assets to Sinopharm (CNCM ltd) . Deal will be satisfied by issuance of about 214.1 million consideration shares at RMB25.10 per consideration share by Sinopharm (CNCM Ltd) to co . On 20 July,sinopharm (CNCM Ltd) resolved that upon completion of transactions, shall issue 45.0199 million shares by way of non-public offer . Issuance of shares by way of non-public offer to raise proceeds of RMB1.13 billion in aggregate .  Full Article

Sinopharm - Sinopharm Group and unit entered into restructuring framework agreement<1099.HK>
Friday, 6 May 2016 07:05am EDT 

Sinopharm Group Co Ltd <1099.HK>: Sinopharm Group and China national medicines corporation ltd. a subsidiary of company entered into restructuring framework agreement . Pursuant to agreement, co proposes to acquire equity interest in Sinopharm Holding Beijing co,sinopharm medicine holding Beijing huahong and others .  Full Article

Sinopharm entered into EPC general contracting service framework agreement with CNPGC
Thursday, 15 Oct 2015 05:32am EDT 

Sinopharm Group Co Ltd:Continuing connected transactions entering into the EPC general contracting service framework agreement.Says entered into the epc general contracting service framework agreement with the CNPGC.Pursuant to which the CNPGC group will provide EPC general contracting services to the group.  Full Article

Sinopharm Group Co Ltd entered into the equity transfer agreement with Sinopharm Investment
Monday, 17 Aug 2015 05:13am EDT 

Sinopharm Group Co Ltd:Entered into the Equity Transfer Agreement with Sinopharm Investment, the intermediate controlling shareholder of the Company, in respect of acquisition of 20% equity interest in Sinopharm Holding Medical Investment Management Co.Says consideration of 100 million yuan.Upon completion of the transaction under the Equity Transfer Agreement, Sinopharm Holding Medical Investment Management Co. will become a non wholly-owned subsidiary of the Company.  Full Article

More From Around the Web

BRIEF-Sinopharm Group Co records FY net profit of RMB6.89 billion, an increase of 20.04 pct

* Recorded a fy net profit of rmb6,891.60 million, representing an increase of rmb1,150.69 million or 20.04%